To be performed during odd cycles (eg, Cyc les 1, 3, and 5) only. Revised Protocol No.: 04 Date: 31-May-2019 25 Approved 5.0 v Approved 1.0 v Clinical Protocol CA021002 BMS-986226 anti-ICOS Table 2-2: On-treatment Procedural Outline (CA021002) Procedures for Safety Cohort, and Parts A, B, C, D and Ea,bC1C2 to beyondC2 OnlyC2 OnlyNotes Procedure D1 D2D8 ±±1 daysD15 ±1 daysD22 ±1 daysD1 D2D8 ±1 daysEOT c,d,e Urinalysis As clinically indicated.See note in Table 2-1 . See Section 9.4.4 .